AGI.do

Products

What will AGI do for Axitirome?

This classification denotes an anti-lipidemic agent with the molecular formula C25H24FNO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V477CK910J, chemically known as ethyl ( -)-((4-(3-((4-fluorophenyl)hydroxymethyl)-4-hydroxyphenoxy)-3,5-dimethylphenyl)amino)oxoacetate but generally known as axitirome, which bears US NIH Compound Identifier 166559. The term AXITIROME is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 3, 2000, List 44). Most nations schedule axitirome under HS 29242995 and SITC 51479. As of Q4 2014, AXITIROME remains the US FDA Preferred Term for this commodity. Axitirome bears US NLM identifiers UMLS ID C2698282 and NCI Concept Code C75992. SMILES: CCOC(=O)C(=O)NC1=CC(=C(C(=C1)C)OC2=CC(=C(C=C2)O)C(C3=CC=C(C=C3)F)O)C.

How AGI delivers it

Four ways AGI delivers for Axitirome

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Axitirome, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Axitirome, get the professional outcome delivered as software, priced on results, not headcount.

Go deeper

Explore Axitirome

Read the deeper take on agi.asView as markdown